Copyright Reports & Markets. All rights reserved.

Global Diagnostics PCR Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Diagnostics PCR Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Diagnostics PCR Market Size Growth Rate by Product
      • 1.4.2 Digital PCR
      • 1.4.3 Multiple PCR
      • 1.4.4 Other PCR
      • 1.4.5 Other
    • 1.5 Market by End User
      • 1.5.1 Global Diagnostics PCR Market Size Growth Rate by End User
      • 1.5.2 Infection Disease Diagnosis
      • 1.5.3 Cancer
      • 1.5.4 Cardiovascular Disease (CVD)
      • 1.5.5 Genetic Testing
      • 1.5.6 Drug Metabolism
      • 1.5.7 HLA Type Test
      • 1.5.8 Other Clinical Application
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Diagnostics PCR Market Size
      • 2.1.1 Global Diagnostics PCR Revenue 2014-2025
      • 2.1.2 Global Diagnostics PCR Sales 2014-2025
    • 2.2 Diagnostics PCR Growth Rate by Regions
      • 2.2.1 Global Diagnostics PCR Sales by Regions
      • 2.2.2 Global Diagnostics PCR Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Diagnostics PCR Sales by Manufacturers
      • 3.1.1 Diagnostics PCR Sales by Manufacturers
      • 3.1.2 Diagnostics PCR Sales Market Share by Manufacturers
      • 3.1.3 Global Diagnostics PCR Market Concentration Ratio (CR5 and HHI)
    • 3.2 Diagnostics PCR Revenue by Manufacturers
      • 3.2.1 Diagnostics PCR Revenue by Manufacturers (2014-2019)
      • 3.2.2 Diagnostics PCR Revenue Share by Manufacturers (2014-2019)
    • 3.3 Diagnostics PCR Price by Manufacturers
    • 3.4 Diagnostics PCR Manufacturing Base Distribution, Product Types
      • 3.4.1 Diagnostics PCR Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Diagnostics PCR Product Type
      • 3.4.3 Date of International Manufacturers Enter into Diagnostics PCR Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Diagnostics PCR Sales by Product
    • 4.2 Global Diagnostics PCR Revenue by Product
    • 4.3 Diagnostics PCR Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Diagnostics PCR Breakdown Data by End User

    6 North America

    • 6.1 North America Diagnostics PCR by Countries
      • 6.1.1 North America Diagnostics PCR Sales by Countries
      • 6.1.2 North America Diagnostics PCR Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Diagnostics PCR by Product
    • 6.3 North America Diagnostics PCR by End User

    7 Europe

    • 7.1 Europe Diagnostics PCR by Countries
      • 7.1.1 Europe Diagnostics PCR Sales by Countries
      • 7.1.2 Europe Diagnostics PCR Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Diagnostics PCR by Product
    • 7.3 Europe Diagnostics PCR by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Diagnostics PCR by Countries
      • 8.1.1 Asia Pacific Diagnostics PCR Sales by Countries
      • 8.1.2 Asia Pacific Diagnostics PCR Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Diagnostics PCR by Product
    • 8.3 Asia Pacific Diagnostics PCR by End User

    9 Central & South America

    • 9.1 Central & South America Diagnostics PCR by Countries
      • 9.1.1 Central & South America Diagnostics PCR Sales by Countries
      • 9.1.2 Central & South America Diagnostics PCR Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Diagnostics PCR by Product
    • 9.3 Central & South America Diagnostics PCR by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Diagnostics PCR by Countries
      • 10.1.1 Middle East and Africa Diagnostics PCR Sales by Countries
      • 10.1.2 Middle East and Africa Diagnostics PCR Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Diagnostics PCR by Product
    • 10.3 Middle East and Africa Diagnostics PCR by End User

    11 Company Profiles

    • 11.1 Abbott Laboratories
      • 11.1.1 Abbott Laboratories Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Abbott Laboratories Diagnostics PCR Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Abbott Laboratories Diagnostics PCR Products Offered
      • 11.1.5 Abbott Laboratories Recent Development
    • 11.2 Agilent Technologies Inc.
      • 11.2.1 Agilent Technologies Inc. Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Agilent Technologies Inc. Diagnostics PCR Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Agilent Technologies Inc. Diagnostics PCR Products Offered
      • 11.2.5 Agilent Technologies Inc. Recent Development
    • 11.3 Alere Inc.
      • 11.3.1 Alere Inc. Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Alere Inc. Diagnostics PCR Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Alere Inc. Diagnostics PCR Products Offered
      • 11.3.5 Alere Inc. Recent Development
    • 11.4 Asuragen, Inc.
      • 11.4.1 Asuragen, Inc. Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Asuragen, Inc. Diagnostics PCR Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Asuragen, Inc. Diagnostics PCR Products Offered
      • 11.4.5 Asuragen, Inc. Recent Development
    • 11.5 Biocartis Group Nv
      • 11.5.1 Biocartis Group Nv Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Biocartis Group Nv Diagnostics PCR Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Biocartis Group Nv Diagnostics PCR Products Offered
      • 11.5.5 Biocartis Group Nv Recent Development
    • 11.6 Biofire Diagnostics, Llc. (Acquired By Biomerieux)
      • 11.6.1 Biofire Diagnostics, Llc. (Acquired By Biomerieux) Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Biofire Diagnostics, Llc. (Acquired By Biomerieux) Diagnostics PCR Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Biofire Diagnostics, Llc. (Acquired By Biomerieux) Diagnostics PCR Products Offered
      • 11.6.5 Biofire Diagnostics, Llc. (Acquired By Biomerieux) Recent Development
    • 11.7 Biomerieux Sa
      • 11.7.1 Biomerieux Sa Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Biomerieux Sa Diagnostics PCR Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Biomerieux Sa Diagnostics PCR Products Offered
      • 11.7.5 Biomerieux Sa Recent Development
    • 11.8 Bio-Rad Laboratories, Inc.
      • 11.8.1 Bio-Rad Laboratories, Inc. Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Bio-Rad Laboratories, Inc. Diagnostics PCR Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Bio-Rad Laboratories, Inc. Diagnostics PCR Products Offered
      • 11.8.5 Bio-Rad Laboratories, Inc. Recent Development
    • 11.9 Cepheid (A Danaher Company)
      • 11.9.1 Cepheid (A Danaher Company) Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Cepheid (A Danaher Company) Diagnostics PCR Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Cepheid (A Danaher Company) Diagnostics PCR Products Offered
      • 11.9.5 Cepheid (A Danaher Company) Recent Development
    • 11.10 Genmark Diagnostics, Inc.
      • 11.10.1 Genmark Diagnostics, Inc. Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Genmark Diagnostics, Inc. Diagnostics PCR Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Genmark Diagnostics, Inc. Diagnostics PCR Products Offered
      • 11.10.5 Genmark Diagnostics, Inc. Recent Development
    • 11.11 Hologic, Inc.
    • 11.12 Luminex Corporation
    • 11.13 Meridian Bioscience, Inc.
    • 11.14 Qiagen N.V.
    • 11.15 Quantumdx Group
    • 11.16 Roche
    • 11.17 Spartan Bioscience
    • 11.18 T2 Biosystems

    12 Future Forecast

    • 12.1 Diagnostics PCR Market Forecast by Regions
      • 12.1.1 Global Diagnostics PCR Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Diagnostics PCR Revenue Forecast by Regions 2019-2025
    • 12.2 Diagnostics PCR Market Forecast by Product
      • 12.2.1 Global Diagnostics PCR Sales Forecast by Product 2019-2025
      • 12.2.2 Global Diagnostics PCR Revenue Forecast by Product 2019-2025
    • 12.3 Diagnostics PCR Market Forecast by End User
    • 12.4 North America Diagnostics PCR Forecast
    • 12.5 Europe Diagnostics PCR Forecast
    • 12.6 Asia Pacific Diagnostics PCR Forecast
    • 12.7 Central & South America Diagnostics PCR Forecast
    • 12.8 Middle East and Africa Diagnostics PCR Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Diagnostics PCR Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Diagnostics PCR market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Diagnostics PCR market based on company, product type, end user and key regions.

      This report studies the global market size of Diagnostics PCR in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Diagnostics PCR in these regions.
      This research report categorizes the global Diagnostics PCR market by top players/brands, region, type and end user. This report also studies the global Diagnostics PCR market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Abbott Laboratories
      Agilent Technologies Inc.
      Alere Inc.
      Asuragen, Inc.
      Biocartis Group Nv
      Biofire Diagnostics, Llc. (Acquired By Biomerieux)
      Biomerieux Sa
      Bio-Rad Laboratories, Inc.
      Cepheid (A Danaher Company)
      Genmark Diagnostics, Inc.
      Hologic, Inc.
      Luminex Corporation
      Meridian Bioscience, Inc.
      Qiagen N.V.
      Quantumdx Group
      Roche
      Spartan Bioscience
      T2 Biosystems

      Market size by Product
      Digital PCR
      Multiple PCR
      Other PCR
      Other
      Market size by End User
      Infection Disease Diagnosis
      Cancer
      Cardiovascular Disease (CVD)
      Genetic Testing
      Drug Metabolism
      HLA Type Test
      Other Clinical Application

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Diagnostics PCR market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Diagnostics PCR market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Diagnostics PCR companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Diagnostics PCR submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Diagnostics PCR are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Diagnostics PCR market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now